Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 2,984 | 3,333 | 5,347 | 4,031 | 5,771 |
| Gross Profit | 2,984 | 3,333 | 5,347 | 4,031 | 5,771 |
| Operating Expenses | 40,154 | 39,086 | 42,263 | 44,312 | 54,519 |
| Operating Income | -37,170 | -35,753 | -36,916 | -40,281 | -48,748 |
| Other Income | 1,101 | 1,362 | 1,531 | 1,528 | 1,504 |
| Pre-tax Income | -36,069 | -34,391 | -35,385 | -38,753 | -47,244 |
| Net Income Continuous | -36,069 | -34,391 | -35,385 | -38,753 | -47,244 |
| Net Income | $-36,069 | $-34,391 | $-35,385 | $-38,753 | $-47,244 |
| EPS Basic Total Ops | -1.03 | -0.99 | -1.02 | -1.14 | -1.37 |
| EPS Basic Continuous Ops | -1.03 | -0.99 | -1.02 | -1.14 | -1.37 |
| EPS Diluted Total Ops | -1.03 | -0.99 | -1.02 | -1.14 | -1.37 |
| EPS Diluted Continuous Ops | -1.03 | -0.99 | -1.02 | -1.14 | -1.37 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -0.99 | N/A | N/A | N/A |
| EBITDA(a) | $-36,463 | $-35,088 | $-36,363 | $-39,756 | $-48,123 |